SEC Form 4 · accession 0001140361-15-035476
Opus Genetics, Inc. · IRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter C. Brandt
Director
Period of report
Sep 16, 2015
Accepted (ET)
Sep 18, 2015 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001228627
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.54 | Sep 16, 2015 | A | 90,000 | A | Jun 4, 2016 | Sep 16, 2025 | Common Stock | 90,000 | 90,000 | D |